Matches in Wikidata for { <http://www.wikidata.org/entity/Q85750755> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q85750755 description "article scientifique publié en 2013" @default.
- Q85750755 description "artículu científicu espublizáu n'avientu de 2013" @default.
- Q85750755 description "scientific article published on 01 December 2013" @default.
- Q85750755 description "wetenschappelijk artikel" @default.
- Q85750755 description "наукова стаття, опублікована в грудні 2013" @default.
- Q85750755 name "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 name "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 type Item @default.
- Q85750755 label "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 label "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 prefLabel "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 prefLabel "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 P1433 Q85750755-265E358A-C10E-4157-9AE1-DFA98BE255B4 @default.
- Q85750755 P1476 Q85750755-5DA0095E-61B7-4975-994F-2B2913815F9C @default.
- Q85750755 P2093 Q85750755-3CEB32BA-D21F-4378-9FE8-517838F6F754 @default.
- Q85750755 P2093 Q85750755-688F8B5F-E78D-4D3D-A15B-03111086DD00 @default.
- Q85750755 P2093 Q85750755-9498EBB5-466F-45EC-A25B-90D2C23409DC @default.
- Q85750755 P2093 Q85750755-9D2DF8D0-F4BF-4D63-BE70-A44251AC696F @default.
- Q85750755 P2093 Q85750755-D9E3D246-4A5F-4644-AD1C-E7F3F95F2345 @default.
- Q85750755 P2093 Q85750755-E610C461-105E-43A8-A038-811DC2525EC4 @default.
- Q85750755 P2093 Q85750755-EDC3A34A-1D3E-413E-A968-5EE313F5D217 @default.
- Q85750755 P304 Q85750755-2BA557F7-EDC7-48BD-8A99-342B6FDD5C7A @default.
- Q85750755 P31 Q85750755-C39C10C6-B7E4-48CE-842F-8550B2802AAF @default.
- Q85750755 P356 Q85750755-E8AAB8C5-3AFD-42C9-926D-99BAE2861A26 @default.
- Q85750755 P433 Q85750755-7A6D6EF8-6473-418B-981B-5453F90300A9 @default.
- Q85750755 P478 Q85750755-016BCBE5-AAEA-4EEE-9E66-4474DE8BFB0B @default.
- Q85750755 P577 Q85750755-9E5ADE83-5240-46B9-83F5-A17DF44CEAC6 @default.
- Q85750755 P698 Q85750755-ADB1A2C0-D7ED-4248-BC4F-19E98DA54C3B @default.
- Q85750755 P921 Q85750755-9217732D-1402-4421-8412-88DC26D9D11A @default.
- Q85750755 P356 HJH.0B013E328364F5DE @default.
- Q85750755 P698 24029871 @default.
- Q85750755 P1433 Q6295318 @default.
- Q85750755 P1476 "Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients" @default.
- Q85750755 P2093 "Arjan J Kwakernaak" @default.
- Q85750755 P2093 "Femke Waanders" @default.
- Q85750755 P2093 "Gerjan Navis" @default.
- Q85750755 P2093 "Gozewijn D Laverman" @default.
- Q85750755 P2093 "Maartje C J Slagman" @default.
- Q85750755 P2093 "Martin M Dokter" @default.
- Q85750755 P2093 "Rudolf A de Boer" @default.
- Q85750755 P304 "2425-2432" @default.
- Q85750755 P31 Q13442814 @default.
- Q85750755 P356 "10.1097/HJH.0B013E328364F5DE" @default.
- Q85750755 P433 "12" @default.
- Q85750755 P478 "31" @default.
- Q85750755 P577 "2013-12-01T00:00:00Z" @default.
- Q85750755 P698 "24029871" @default.
- Q85750755 P921 Q736715 @default.